Tony Chen
Founder and Chief Executive Officer · Phrontline Biopharma · Hangzhou, China
Biotechnology · Series A · Founded 2022
Latest raise
$40M
Date raised
November 13, 2026
Round
Series A
About Tony Chen
Phrontline Biopharma develops innovative antibody-drug conjugates (ADCs) focused on oncology therapies.
- Who is Tony Chen?
- Tony Chen is listed as Founder and Chief Executive Officer of Phrontline Biopharma, a biotechnology company founded in 2022 based in Hangzhou, China.
- How much did Phrontline Biopharma raise?
- Phrontline Biopharma raised $40M in a Series A round on November 13, 2026 (9 days ago). Backed by Decheng Capital, Oriza Seed Venture Capital.
Get newly funded founders every week
A free weekly list of startups that just raised.